Gao Qi, Chen Kexin, Gao Lu, Zheng Yang, Yang Yong-Guang
The First Hospital and Institute of Immunology, Jilin University, Changchun, China.
Columbia Center for Translational Immunology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Cell Death Dis. 2016 Sep 8;7(9):e2368. doi: 10.1038/cddis.2016.155.
CD47 signaling in endothelial cells has been shown to suppress angiogenesis, but little is known about the link between CD47 and endothelial senescence. Herein, we demonstrate that the thrombospondin-1 (TSP1)-CD47 signaling pathway is a major mechanism for driving endothelial cell senescence. CD47 deficiency in endothelial cells significantly improved their angiogenic function and attenuated their replicative senescence. Lack of CD47 also suppresses activation of cell cycle inhibitors and upregulates the expression of cell cycle promoters, leading to increased cell cycle progression. Furthermore, TSP1 significantly accelerates replicative senescence and associated cell cycle arrest in a CD47-dependent manner. These findings demonstrate that TSP1-CD47 signaling is an important mechanism driving endothelial cell senescence. Thus, TSP1 and CD47 provide attractive molecular targets for treatment of aging-associated cardiovascular dysfunction and diseases involving endothelial dysregulation.
内皮细胞中的CD47信号已被证明可抑制血管生成,但关于CD47与内皮细胞衰老之间的联系却知之甚少。在此,我们证明血小板反应蛋白-1(TSP1)-CD47信号通路是驱动内皮细胞衰老的主要机制。内皮细胞中CD47的缺乏显著改善了它们的血管生成功能,并减弱了它们的复制性衰老。CD47的缺失还抑制了细胞周期抑制剂的激活并上调了细胞周期促进因子的表达,导致细胞周期进程加快。此外,TSP1以CD47依赖的方式显著加速复制性衰老和相关的细胞周期停滞。这些发现表明TSP1-CD47信号是驱动内皮细胞衰老的重要机制。因此,TSP1和CD47为治疗与衰老相关的心血管功能障碍和涉及内皮失调的疾病提供了有吸引力的分子靶点。